---
title: "IRulya Therapeutics to Participate in Fireside Chat at Craig-Hallum Biotech Catalyst Conference"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/301975281.md"
description: "IRulya Therapeutics senior management will participate in a fireside chat at the Craig-Hallum Biotech Catalyst Conference on October 22, 2026."
datetime: "2026-10-15T12:09:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/301975281.md)
  - [en](https://longbridge.com/en/news/301975281.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/301975281.md)
generator: "portal-rs"
---

# IRulya Therapeutics to Participate in Fireside Chat at Craig-Hallum Biotech Catalyst Conference

-   IRulya Therapeutics senior management will participate in a fireside chat at the Craig-Hallum Biotech Catalyst Conference on October 22, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IRulya Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610150800PRIMZONEFULLFEED9846002) on October 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [IRLA.US](https://longbridge.com/en/quote/IRLA.US.md)
- [QNCX.US](https://longbridge.com/en/quote/QNCX.US.md)

## Related News & Research

- [IRulya Therapeutics Files Initial Beneficial Ownership Statement for Director Leone D. Patterson](https://longbridge.com/en/news/302323886.md)
- [Leerink Partners Reaffirms Their Buy Rating on Quince Therapeutics (QNCX)](https://longbridge.com/en/news/300536854.md)
- [Quince Therapeutics to present at Cantor Global Healthcare Conference](https://longbridge.com/en/news/297909894.md)
- [Quince Therapeutics to host virtual KOL event on PH-ILD, BOS treatment landscape and LAM-001](https://longbridge.com/en/news/299316130.md)
- [Quince Therapeutics raises USD 115 million in private placement of Series C preferred shares](https://longbridge.com/en/news/296091137.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**